We’re In The News

As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.

Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.

Psst! Industry Has Taken Over FDA

Medical Device and Diagnostic Industry, September 17, 2015. By nominating cardiologist Robert M. Califf to be FDA’s next commissioner, the Obama Administration has taken a giant step away from the agency’s traditional avoidance of even the suspicion of coziness with the industries it regulates.

Obama Picks Duke Physician to Head FDA

CQ Roll Call, September 15, 2015. President Obama will nominate Robert Califf to be the next commissioner of the Food and Drug Administration, the White House announced Tuesday. Califf has served as the agency’s deputy commissioner for medical products and tobacco since January. In that role, he oversees the agency’s divisions responsible for tobacco, drugs, medical devices and biological treatments, areas where the FDA is currently drafting new policies and regulations.

Michael Milken, from Junk Bonds to Legislative Advocate

Boston Globe, September 14, 2015. Not everyone is pleased with Milken’s behind-the-scenes advocacy. While supporters say the Cures Act, a version of which was passed by the House in July, would make it cheaper and faster to get cutting-edge drugs and medical devices to patients, critics warn that it would create dangerous regulatory shortcuts.

Letter to the Editor: “Patients Shouldn’t be Used as Guinea Pigs”

Sun Sentinel, September 10, 2015. We need new Alzheimer’s drugs, but we can’t assume new drugs are cures unless they are proven effective and safe.

The Facts About Addyi, Its Side Effects, and Women’s Sex Drive

Our Bodies Ourselves, September 8, 2015. It’s been almost impossible to ignore the media fascination with “pink Viagra” and the public debate about whether the drug flibanserin — soon to go sale as Addyi — should have been approved last month by the Food and Drug Administration. Find out the facts here.